Stone House Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-104
Closed -$2.9K 319
2023
Q3
$2.9K Hold
104
﹤0.01% 237
2023
Q2
$3.54K Hold
104
﹤0.01% 224
2023
Q1
$3.13K Buy
+104
New +$3.22K ﹤0.01% 220

Other funds holding ARKG

Stone House Investment Management's ARKG Position: Q4 2023 in Review

Stone House Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 104 shares — an estimated $2.9K sold.

Stone House Investment Management first reported a position in ARKG in Q1 2023 and held it in 3 quarters. The position peaked at $3.54K in Q2 2023. 299 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Stone House Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Stone House Investment Management sold 104 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $2.9K.
  • Stone House Investment Management first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 3 quarters.
  • Stone House Investment Management's ARK Genomic Revolution ETF position peaked at $3.54K in Q2 2023.
  • 299 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Stone House Investment Management's 13F filing for Q4 2023, filed 31 Jan 2024.